Memorial Sloan Kettering Cancer Center – MSKCC shared a post on LinkedIn:
“For more than two decades, physician-scientist Dr. Omar Abdel-Wahab has been known across Memorial Sloan Kettering Cancer Center (MSK) for his insight, knowledge, and creativity as a cancer researcher. Now he will also be known as a 2025 Paul Marks Prize winner, the first recipient from MSK since 2003.
A leader in developing better treatments for a range of blood cancers including myelodysplastic syndrome (MDS) and histiocytosis, Dr. Abdel-Wahab is an attending physician on the Leukemia Service at MSK and Chair of the Molecular Pharmacology Program in the Sloan Kettering Institute (SKI).
Learn more about his path and what inspires his work.”
More posts featuring Omar Abdel-Wahab.